Parkinson's Disease Treatments
Find Parkinson's Disease Treatments
Generic Name
Selegiline
Brand Names
EMSAM, Zelapar
FDA approval date: August 02, 1996
Classification: Monoamine Oxidase Inhibitor
Form: Patch, Tablet, Capsule
What is EMSAM (Selegiline)?
EMSAM is a monoamine oxidase inhibitor indicated for the treatment of adults with major depressive disorder . EMSAM ® is a monoamine oxidase inhibitor indicated for the treatment of major depressive disorder .
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment